Eisai Co., Ltd. · Tokyo Japan
| 4-6-10 Koishikawa, Bunkyo-Ku | Phone: +81-3-3817-3700 |
| Tokyo | Fax: +81-3-3811-3077 |
| 112-8088 | |
| Japan | 
Map This Company |
- Company Profiles
- Competitive Landscapes
- Industry Reports
Buy Reports
For a Hoover's Free Trial, Call
(866) 444-8642or
Chat NowCompany Description
Eisai develops, manufactures, and distributes prescription pharmaceuticals, primarily in North America and Japan. Prescription drug sales account for a majority of the company's revenues and are led by Aricept, which treats Alzheimer's disease. Other drugs include Myonal, a muscle relaxant, and AcipHex, an acid reflux and ulcer treatment (sold as Pariet in Japan and Europe). Development programs target neurology, oncology, vascular, and immunological ailments. In Japan the company distributes generic and non-prescription drugs and consumer health products. Eisai also makes food additives and chemicals, in addition to drug manufacturing equipment and systems.
Eisai Co., Ltd. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Executives
37 executives listed for Eisai Co., Ltd.'s Tokyo, Japan location.
| President, CEO, and Director | Haruo Naito | E-mail |
|---|
| EVP Customer Joy and CFO | Hideaki Matsui | E-mail |
|---|
| VP Corporate Management Planning and Information System | Kazuo Hirai | E-mail |
|---|
More Eisai Co., Ltd. Executives
Top Eisai Co., Ltd. Competitors
